Genespire is a biotechnology company focused on the development of durable and transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases. Based in Milan, Italy, Genespire was founded in March 2020 by the gene therapy pioneer Prof. Luigi Naldini, Dr. Alessio Cantore, Fondazione Telethon and Ospedale San Raffaele. It is a spin-off of SR-Tiget, a world leading cell and gene therapy research institute and is backed by Sofinnova Partners.
Company Details
- Employees
- 14
- Founded
- -
- Address
- Via Vincenzo Gioberti, 8,italy
- Phone
- 39 02 83991300
- in****@****ire.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- genespire.com
- HQ
- Milan, Lombardy
Genespire Questions
Genespire's helpline number is 39 02 83991300
Genespire's website is genespire.com
Genespire's LinkedIn profile is https://it.linkedin.com/company/genespire
Genespire has
14 employees.
View email and phone details for 14
employees at Genespire.
Genespire's industry is
Biotechnology Research
Genespire's top competitors are
Telesis Bio,
Lift Biosciences,
Constructive Bio,
Vicebio,
858 Therapeutics,
Emergent Biosolutions,
Biohaven,
Bioage Labs,
Longbio Pharma,
Agc Biologics.
Genespire's support email address is info@genespire.com
Genespire's categories are Biotechnology Research
Genespire's founding year is 2020
